Loading data…
Akari Therapeutics Plc
18 transactions · Newest trade first
Accepted in the last 30 daysNo qualifying insider buying. No qualifying insider sales.
Filing activity uses public SEC acceptance timestamps. The qualifying-buys metric above uses trade dates at the snapshot cutoff.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
Signal Score describes disclosed qualifying corporate insider buying over up to 180 trade-date days. Congress trades do not contribute. It is not a measure of company quality, investment safety or profit probability. A zero means no points in the scored evidence; unavailable means imported scoring evidence is missing. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Score is not a probability of profit or a recommendation to trade.
This reflects the filings imported so far, not a complete trading history.